Exploring how next-generation sequencing technology is transforming minimal residual disease detection in pediatric B-acute lymphoblastic leukemia treatment.
Explore how John Powers and Murrieta Genomics are transforming healthcare through genomic medicine, next-generation sequencing, and personalized cancer treatments.
Exploring how epigenomics and long-read sequencing are transforming medicine through multi-omic integration and epigenetic editing.